We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$62.6B
AUM Growth
+$3.39B
Cap. Flow
+$15.3B
Cap. Flow %
24.46%
Top 10 Hldgs %
15.8%
Holding
3,198
New
158
Increased
1,015
Reduced
1,431
Closed
206

Top Buys

Rank Stock Value
1
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$11.9B
2
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$4.57B
3
KKR.PRC
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
+$340M
4
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
+$145M
5
O icon
Realty Income
O
+$88.5M

Top Sells

Rank Stock Value
1
CNP icon
CenterPoint Energy
CNP
+$97.8M
2
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$91.3M
3
CONE
CyrusOne Inc Common Stock
CONE
+$70.5M
4
LEN icon
Lennar Class A
LEN
+$66M
5
VER
VEREIT, Inc.
VER
+$65.2M

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Financials 13.75%
3 Healthcare 12.67%
4 Consumer Discretionary 10.18%
5 Real Estate 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCI
2851
DELISTED
Lannett Company, Inc.
LCI
$18K ﹤0.01%
2,800
-18,965
-87% -$162K
LCTX icon
2852
Lineage Cell Therapeutics
LCTX
$278M
$17K ﹤0.01%
6,964
-5,420
-44% -$12.7K
VIOT
2853
Viomi Technology
VIOT
$49.4M
$17K ﹤0.01%
7,311
– –
OSH
2854
DELISTED
Oak Street Health, Inc.
OSH
$17K ﹤0.01%
536
-34,786
-98% -$1.32M
ABUS icon
2855
Arbutus Biopharma
ABUS
$923M
$16K ﹤0.01%
4,120
-4,323
-51% -$16.8K
MSTR icon
2856
Strategy Inc
MSTR
$37.6B
$16K ﹤0.01%
310
– –
VTGN icon
2857
VistaGen Therapeutics
VTGN
$11.2M
$16K ﹤0.01%
277
– –
JNCE
2858
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$16K ﹤0.01%
2,017
– –
ORIC icon
2859
Oric Pharmaceuticals
ORIC
$1.43B
$14K ﹤0.01%
1,004
– –
SYRE icon
2860
Spyre Therapeutics
SYRE
$8.87B
$14K ﹤0.01%
120
– –
BFX
2861
DELISTED
BowFlex Inc.
BFX
$14K ﹤0.01%
2,418
-78,062
-97% -$647K
ACOR
2862
DELISTED
Acorda Therapeutics
ACOR
$14K ﹤0.01%
300
– –
SRNE
2863
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$14K ﹤0.01%
3,200
– –
CRIS icon
2864
Curis
CRIS
$4.85M
$13K ﹤0.01%
7
– –
CUE icon
2865
Cue Biopharma
CUE
$110M
$13K ﹤0.01%
40
– –
NOVT icon
2866
Novanta
NOVT
$6.25B
$13K ﹤0.01%
76
-1,524
-95% -$255K
FUTU icon
2867
Futu Holdings
FUTU
$14.9B
$11K ﹤0.01%
256
– –
XBIT icon
2868
XBiotech
XBIT
$69.2M
$11K ﹤0.01%
1,023
– –
LGF.B
2869
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$11K ﹤0.01%
726
-179,700
-100% -$2.52M
BYSI icon
2870
BeyondSpring
BYSI
$32.5M
$10K ﹤0.01%
2,240
– –
FNWD icon
2871
Finward Bancorp
FNWD
$193M
$10K ﹤0.01%
+221
New +$10.6K
DNTH icon
2872
Dianthus Therapeutics
DNTH
$6.22B
$9K ﹤0.01%
134
– –
VIVS
2873
VivoSim Labs
VIVS
$1.23M
$9K ﹤0.01%
210
– –
NERV icon
2874
Minerva Neurosciences
NERV
$215M
$7K ﹤0.01%
1,175
-10,394
-90% -$97.9K
AAIC
2875
DELISTED
Arlington Asset Investment Corp.
AAIC
$7K ﹤0.01%
2,259
– –
113 114
115
116 117

Similar funds

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Russell Investments Group's Q4 2021 Portfolio in Review

As of Q4 2021, Russell Investments Group held 3,198 positions worth $62.6B, up 5.7% from $59.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Russell Investments Group deployed $15.3B of net new capital in Q4 2021, opening 158 new positions and adding to 1,015 existing holdings. Its largest new stake was Bank of America Series L: 8,245,000 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CenterPoint Energy, an estimated $97.8M trimmed.

  • Russell Investments Group's largest Q4 2021 buy was Bank of America Series L: 8,245,000 shares worth $11.9M.
  • Russell Investments Group added most to Realty Income in Q4 2021, an estimated $88.5M increase.
  • Russell Investments Group's biggest Q4 2021 reduction was CenterPoint Energy, cutting an estimated $97.8M.
  • Russell Investments Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $65.2M.
  • Russell Investments Group's ten largest holdings make up 16% of its $62.6B portfolio in Q4 2021.
  • Russell Investments Group opened 158 new positions and closed 206 in Q4 2021.
  • Russell Investments Group's portfolio value rose 5.7% quarter-over-quarter to $62.6B.

Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.